Drug Profile
Brefeldin A
Alternative Names: BFA; NSC 89671Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Unknown
- Developer Braton Biotech; Nonindustrial source
- Class Cytostatic antibiotics; Macrolides
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; HIV infections; Inflammation